Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Ciclopirox (olamine)

Product Specifications

UNSPSC Description

Ciclopirox olamine (Ciclopirox ethanolamine) is a synthetic and orally active antifungal agent that can be used for superficial mycoses reseaech. Ciclopirox olamine has a very broad spectrum of activity and inhibits dermatophytes, yeasts, molds, and many Gram-positive and Gram-negative species pathogenic. Ciclopirox olamine also has anticancer and anti-inflammatory effect[1][2][3].

Target Antigen

Bacterial; Ferroptosis; Fungal

Type

Reference compound

Related Pathways

Anti-infection;Apoptosis

Applications

COVID-19-immunoregulation

Field of Research

Infection; Cancer

Assay Protocol

https://www.medchemexpress.com/Ciclopirox-olamine.html

Purity

99.78

Solubility

DMSO : 25 mg/mL (ultrasonic;warming;heat to 60°C)

Smiles

O=C1C=C(C)C=C(C2CCCCC2)N1O.NCCO

Molecular Weight

268.35

References & Citations

[1]Niewerth M, et al. Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors. Antimicrob Agents Chemother. 2003 Jun;47(6):1805-17.|[2]Leem, S.H., et al., The possible mechanism of action of ciclopirox olamine in the yeast Saccharomyces cerevisiae. Mol Cells, 2003. 15(1): p. 55-61.|[3]Ratnavel, R.C., R.A. Squire, and G.C. Boorman, Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis. J Dermatolog Treat, 2007. 18(2): p. 88-96.|[4]Clement PM, et al. The antifungal drug ciclopirox inhibits deoxyhypusine and proline hydroxylation, endothelial cell growth and angiogenesis in vitro. Int J Cancer. 2002 Aug 1;100(4):491-8.|[5]Lu J, et al. Ciclopirox targets cellular bioenergetics and activates ER stress to induce apoptosis in non-small cell lung cancer cells. Cell Commun Signal. 2022 Mar 24;20(1):37.|[6]Zhou H, et al. The antitumor activity of the fungicide ciclopirox. Int J Cancer. 2010 Nov 15;127(10):2467-77.Pharmacol Res. 7 January 2022, 106046.|Clin Transl Med. 2022 Aug;12(8):e999.|Eur J Pharmacol. 2022 Jul 19;175156.|Front Pharmacol. 2021 May 10;12:670224.|Mol Cell Biochem. 2024 May 24.|Mol Neurobiol. 2024 Oct 10.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-B0450A/Ciclopirox-olamine-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-B0450A/Ciclopirox-olamine-SDS-MedChemExpress.pdf

Clinical Information

Launched

CAS Number

41621-49-2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

SEPT11 Protein Vector (Human) (pPM-C-HA)
43394021 500 ng

SEPT11 Protein Vector (Human) (pPM-C-HA)

Ask
View Details
TMUB2 Protein Vector (Human) (pPM-C-HA)
47181022 500 ng

TMUB2 Protein Vector (Human) (pPM-C-HA)

Ask
View Details
Mouse Monoclonal Vimentin Antibody (RV202) [DyLight 405]
NBP1-97672V 0.1 mL

Mouse Monoclonal Vimentin Antibody (RV202) [DyLight 405]

Ask
View Details
Recombinant Thermodesulfovibrio yellowstonii Ribosome-binding factor A (rbfA)
MBS1158766-01 0.02 mg (E-Coli)

Recombinant Thermodesulfovibrio yellowstonii Ribosome-binding factor A (rbfA)

Ask
View Details
Recombinant Thermodesulfovibrio yellowstonii Ribosome-binding factor A (rbfA)
MBS1158766-02 0.1 mg (E-Coli)

Recombinant Thermodesulfovibrio yellowstonii Ribosome-binding factor A (rbfA)

Ask
View Details
Recombinant Thermodesulfovibrio yellowstonii Ribosome-binding factor A (rbfA)
MBS1158766-03 0.02 mg (Yeast)

Recombinant Thermodesulfovibrio yellowstonii Ribosome-binding factor A (rbfA)

Ask
View Details